[ORGANIZATION]
OncoC4
Featured in 2 tracked stories · first seen
Situations
BioNTech lung cancer clinical trial developments
2 clusters · 13 sources · last updated
Latest: BioNTech reports positive lung cancer clinical trial data
BioNTech has reported positive results from clinical trials targeting lung cancer. In the Phase 3 PRESERVE-003 study, the experimental antibody Gotistobart (BNT316/ONC-392), developed with U.S.-based OncoC4, showed a med